Krystal Biotech, Inc.KRYSNASDAQ
Loading
Gross profit as a percentage of revenue
5Y CAGR
+1.4%/yr
Long-term compound
Percentile
P60
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | 92.61% | -0.5% |
| 2024 | 93.09% | -0.9% |
| 2023 | 93.90% | - |
| 2022 | 0.00% | - |
| 2021 | 0.00% | -100.0% |
| 2018 | 86.27% | - |